Work

Fenofibrate in the Management of Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

Year: 2024

Type: preprint

Study designs: Randomized Controlled Trial, Clinical Trial

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.4916039

Authors: Avner Ehrlich, Yuval Daskal, Makram Nasar, Ismaeel Abu Alkian, Vladimir Chitoroga, Majd Khader, Asad Rizek, Hikmat Badrane, Rimon Artul, Nir Rainy, Mario L. Morieri, Chiara Pavanello, Cesare R. Sirtori, Merav Cohen, Amichai Gotlieb, Shlomo L. Maayan, Yaakov Nahmias

Institutions: Hebrew University of Jerusalem, Barzilai Medical Center, Assaf Harofeh Medical Center, University of Padua, University of Milan, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4401389190

Cites:

Cited by:

Related to: 10